Combination of Anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 4, 2011, Pages 1179-1187

  Riesterer, Oliver ^a   Yang, Qiuan ^a   Raju, Uma ^a   Torres, Mylin ^a   Molkentine, David ^a   Patel, Nalini ^a   Valdecanas, David ^a   Milas, Luka ^a   Ang, K Kian ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

A12; Head and neck cancer; Insulin like growth factor receptor 1; Lung cancer; Radiation

Indexed keywords

A12; APOPTOSIS; APOPTOSIS INDUCTION; CANCER CELLS; CELL LINES; CETUXIMAB; COMBINED TREATMENT; DOSE-DEPENDENT MANNER; ENHANCEMENT FACTOR; HEAD-AND-NECK CANCER; HUMAN CANCER CELLS; IMMUNOHISTOCHEMICAL ANALYSIS; IMMUNOHISTOCHEMICAL ASSAYS; IN-VITRO; IN-VIVO; INSULIN-LIKE GROWTH FACTOR RECEPTOR 1; LUNG CANCER; RADIATION RESISTANCE; RADIATION RESPONSE; SIGNALING PATHWAYS; TUMOR CELLS; TUMOR XENOGRAFTS; UPPER AERODIGESTIVE TRACTS; UPPER RESPIRATORY TRACT; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANTIBODIES; BIOLOGICAL MATERIALS; BIOLOGICAL ORGANS; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; DISEASES; INSULIN; IONIZING RADIATION; PEPTIDES; SELF ASSEMBLY; TUMORS;

RADIOTHERAPY;

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY IMC A12; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; RESPIRATORY TRACT CANCER; TREATMENT RESPONSE; TUMOR XENOGRAFT; UPPER RESPIRATORY TRACT CANCER;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NECROSIS; NEOPLASM PROTEINS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RECEPTOR, IGF TYPE 1; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79951943282     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.10.003     Document Type: Article

References (43)

1. O. Larsson, A. Girnita, and L. Girnita Role of insulin-like growth factor 1 receptor signalling in cancer Br J Cancer 92 2005 2097 2101 (Pubitemid 40966242)
2. B.S. Miller, and D. Yee Type I insulin-like growth factor receptor as a therapeutic target in cancer Cancer Res 65 2005 10123 10127 (Pubitemid 41743697)
3. M.N. Pollak, E.S. Schernhammer, and S.E. Hankinson Insulin-like growth factors and neoplasia Nat Rev Cancer 4 2004 505 518 (Pubitemid 38868620)
4. Y. Tao, V. Pinzi, and J. Bourhis Mechanisms of disease: Signaling of the insulin-like growth factor 1 receptor pathway - therapeutic perspectives in cancer Nat Clin Pract Oncol 4 2007 591 602 (Pubitemid 47534758)
5. H. Werner, and D. Le Roith The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis Crit Rev Oncol 8 1997 71 92 (Pubitemid 28131305)
6. R. Baserga, F. Peruzzi, and K. Reiss The IGF-1 receptor in cancer biology Int J Cancer 107 2003 873 877 (Pubitemid 37429826)
7. A. Chakravarti, J.S. Loeffler, and N.J. Dyson Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling Cancer Res 62 2002 200 207 (Pubitemid 34074005)
8. M.A. Rochester, J. Riedemann, and G.O. Hellawell Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer Cancer Gene Ther 12 2005 90 100 (Pubitemid 39665247)
9. A.H. Yeh, E.A. Bohula, and V.M. Macaulay Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs Oncogene 25 2006 6574 6581 (Pubitemid 44646185)
10. J.M. Carboni, A.V. Lee, and D.L. Hadsell Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor Cancer Res 65 2005 3781 3787 (Pubitemid 40616356)
11. C. Sell, G. Dumenil, and C. Deveaud Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts Mol Cell Biol 14 1994 3604 3612 (Pubitemid 24160768)
12. F. Peruzzi, M. Prisco, and M. Dews Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis Mol Cell Biol 19 1999 7203 7215 (Pubitemid 29441900)
13. A.M. Vincent, and E.L. Feldman Control of cell survival by IGF signaling pathways Growth Horm IGF Res 12 2002 193 197 (Pubitemid 35230190)
14. N. Reinmuth, W. Liu, and F. Fan Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer Clin Cancer Res 8 2002 3259 3269 (Pubitemid 35155039)
15. H. Zeng, K. Datta, and M. Neid Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line Biochem Biophys Res Commun 302 2003 46 55 (Pubitemid 36268917)
16. X. Zhang, M. Lin, and K.L. van Golen Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration Breast Cancer Res Treat 93 2005 159 168 (Pubitemid 41396777)
17. P.A. Pennisi, V. Barr, and N.P. Nunez Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype Cancer Res 62 2002 6529 6537 (Pubitemid 35364118)
18. J.L. Gooch, C.L. Van Den Berg, and D. Yee Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death: proliferative and anti-apoptotic effects Breast Cancer Res Treat 56 1999 1 10 (Pubitemid 29435810)
19. E.S. Perer, A.K. Madan, and A. Shurin Insulin-like growth factor I receptor antagonism augments response to chemoradiation therapy in colon cancer cells J Surg Res 94 2000 1 5
20. E.K. Rowinsky, H. Youssoufian, and J.R. Tonra IMC-A12, a human IgG1 monoclonal antibody to the insulin-like growth factor I receptor Clin Cancer Res 13 2007 5549s 5555s (Pubitemid 47510386)
21. K.D. Wu, L. Zhou, and D. Burtrum Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis Cancer Immunol Immunother 56 2007 343 357 (Pubitemid 46035904)
22. J.D. Wu, K. Haugk, and I. Coleman Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors Clin Cancer Res 12 2006 6153 6160 (Pubitemid 44703781)
23. G.W. Allen, C. Saba, and E.A. Armstrong Insulin-like growth factor-I receptor signaling blockade combined with radiation Cancer Res 67 2007 1155 1162
24. D. Cosaceanu, R.A. Budiu, and M. Carapancea Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism Oncogene 26 2007 2423 2434 (Pubitemid 46597267)
25. V.M. Macaulay, A.J. Salisbury, and E.A. Bohula Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase Oncogene 20 2001 4029 4040 (Pubitemid 32681608)
26. S. Peretz, R. Jensen, and R. Baserga ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response Proc Natl Acad Sci U S A 98 2001 1676 1681 (Pubitemid 32165557)
27. M. Tezuka, H. Watanabe, and S. Nakamura Antiapoptotic activity is dispensable for insulin-like growth factor I receptor-mediated clonogenic radioresistance after gamma-irradiation Clin Cancer Res 7 2001 3206 3214 (Pubitemid 32963845)
28. D. Burtrum, Z. Zhu, and D. Lu A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo Cancer Res 63 2003 8912 8921 (Pubitemid 38064071)
29. B. Fertil, and E.P. Malaise Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy Int J Radiat Oncol Biol Phys 7 1981 621 629 (Pubitemid 11072545)
30. U. Raju, E. Nakata, and K.A. Mason Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells Cancer Res 63 2003 3263 3267 (Pubitemid 36735881)
31. W.Y. Kim, Q. Jin, and S.H. Oh Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development Cancer Res 69 2009 7439 7448
32. Y. Akagi, W. Liu, and B. Zebrowski Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I Cancer Res 58 1998 4008 4014 (Pubitemid 28405661)
33. O. Stoeltzing, W. Liu, and N. Reinmuth Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer Am J Pathol 163 2003 1001 1011 (Pubitemid 37040136)
34. R.S. Warren, H. Yuan, and M.R. Matli Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma J Biol Chem 271 1996 29483 29488 (Pubitemid 26382669)
35. A.P. Gilmore, A.J. Valentijn, and P. Wang Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor J Biol Chem 277 2002 27643 27650 (Pubitemid 34966707)
36. B. Liu, M. Fang, and Y. Lu Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody Oncogene 20 2001 1913 1922 (Pubitemid 32458701)
37. Y. Wang, and Y. Sun Insulin-like growth factor receptor-1 as an anti-cancer target: Blocking transformation and inducing apoptosis Curr Cancer Drug Targets 2 2002 191 207
38. D. Sachdev, S.L. Li, and J.S. Hartell A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I Cancer Res 63 2003 627 635 (Pubitemid 36158140)
39. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
40. H.E. Jones, L. Goddard, and J.M. Gee Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells Endocr Relat Cancer 11 2004 793 814 (Pubitemid 40065552)
41. Y. Lu, X. Zi, and Y. Zhao Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin) J Natl Cancer Inst 93 2001 1852 1857 (Pubitemid 34048651)
42. F. Morgillo, J.K. Woo, and E.S. Kim Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib Cancer Res 66 2006 10100 10111 (Pubitemid 44672064)
43. C.J. Barnes, K. Ohshiro, and S.K. Rayala Insulin-like growth factor receptor as a therapeutic target in head and neck cancer Clin Cancer Res 13 2007 4291 4299 (Pubitemid 47105993)